Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
127.38%
↑ 159% above average
Average (9y)
49.21%
Historical baseline
Range
High:142.93%
Low:-56.44%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 127.38% |
| 2023 | 0.76% |
| 2022 | 142.93% |
| 2021 | -37.12% |
| 2020 | 125.45% |
| 2019 | 96.47% |
| 2018 | 128.01% |
| 2017 | 10.86% |
| 2016 | -56.44% |
| 2015 | -46.25% |